Total trials
166
Active
46
Phase 3
0
Total enrollment
15,558
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Combined Intravenous-Inhalational Anesthesia | — | — | — | — | — | 1 | |
| Inhalational Anesthesia Only | — | — | — | — | — | 1 | |
| Nebulize Lidocaine | — | — | — | — | — | 1 | |
| Nebulize %3 Sodium Chloride | — | — | — | — | — | 1 |
Next readouts
- 2026-06-15
- 2027-04
Top conditions
- Breastfeeding6
- Educational Problems6
- Children4
- Pregnant Women3
- Education3
- Pain3
- Gamification3
- Regional Anesthesia3
Frequently asked questions about Sakarya University
- How many clinical trials does Sakarya University have on ClinicalTrials.gov?
- Sakarya University is listed as the lead sponsor on 166 clinical trials in ClinicalTrials.gov, 46 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Sakarya University's trials are in Phase 3?
- 0 of Sakarya University's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Sakarya University focus on?
- Sakarya University's most-studied conditions on ClinicalTrials.gov are Breastfeeding, Educational Problems, Children, Pregnant Women, Education.
- When are Sakarya University's next clinical trial readouts?
- Sakarya University has 2 upcoming primary-completion readouts tracked here; the soonest is “Nebulized Lidocaine vs 3% Sodium Chloride in Pediatric Adenoid/Tonsil Surgery”, expected around 2026-06-15.